Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50–59 Years at Increased Risk of Severe RSV Disease
| Title: | Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50–59 Years at Increased Risk of Severe RSV Disease |
|---|---|
| Authors: | Singer, DavidAff1, IDs40121025012388_cor1; La, Elizabeth M.Aff1; Graham, JonathanAff2; Molnar, DanielAff3; Grace, MeiAff2; Poston, SaraAff1; Verelst, FrederikAff3 |
| Source: | Infectious Diseases and Therapy. 14(12):2743-2761 |
| Database: | Springer Nature Journals |